Effects of some antipsychotics and a benzodiazepine hypnotic on the sleep-wake pattern in an animal model of schizophrenia

Journal of Pharmacological Sciences

Volumn 111, Issue 1, 2009, Pages 44-52

  Ishida, Takayuki ^a   Obara, Yoshihito ^a   Kamei, Chiaki ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Antipsychotic; Benzodiazepine hypnotic; MK 801; Schizophrenia; Sleep wake pattern

Indexed keywords

ARIPIPRAZOLE; BENZODIAZEPINE; DIZOCILPINE; EBILIFY; FLUNITRAZEPAM; HALOPERIDOL; HYPNOTIC AGENT; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DRUG EFFECT; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; MALE; NECK MUSCLE; NONHUMAN; NONREM SLEEP; RAT; REM SLEEP; SCHIZOPHRENIA; SLEEP; SLEEP WAKING CYCLE;

ANIMALS; ANTI-ANXIETY AGENTS; ANTIPSYCHOTIC AGENTS; DISEASE MODELS, ANIMAL; DIZOCILPINE MALEATE; DRUG INTERACTIONS; ELECTROENCEPHALOGRAPHY; FLUNITRAZEPAM; HYPNOTICS AND SEDATIVES; MALE; RATS; RATS, WISTAR; SCHIZOPHRENIA; SLEEP DISORDERS; SLEEP STAGES; TIME FACTORS; WAKEFULNESS;

EID: 70349510451     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.09142FP     Document Type: Article

References (35)

1. Hiatt JF, Floyd TC, Katz PH, Feinberg I. Further evidence of abnormal non-rapid-eye-movement sleep in schizophrenia. Arch Gen Psychiatry. 1985;42:797-802. (Pubitemid 15244830)
2. Keshavan MS, Reynolds CF, Kupfer DJ. Electroencephalographic sleep in schizophrenia: a critical review. Compr Psychiatry. 1990;31:34-47. (Pubitemid 20065981)
3. Salin-Pascual RJ, Herrera-Estrella M, Galicia-Polo L, Rosas M, Brunner E. Low delta sleep predicted a good clinical response to olanzapine administration in schizophrenic patients. Rev Invest Clin. 2004;56:345-350. (Pubitemid 39232132)
4. Levin ED, Caldwell DP, Perraut C. Clozapine treatment reverses dizocilpine-induced deficits of pre-pulse inhibition of tactile startle response. Pharmacol Biochem Behav. 2007;86:597-605. (Pubitemid 46466893)
5. Matsuoka T, Sumiyoshi T, Tanaka K, Tsunoda M, Uehara T, Itoh H, et al. NC-1900, an arginine-vasopressin analogue, ameliorates social behavior deficits and hyperlocomotion in MK-801-treated rats: therapeutic implications for schizophrenia. Brain Res. 2005;1053:131-136. (Pubitemid 41116798)
6. Manahan-Vaughan D, von Haebler D, Winter C, Juckel G, Heinemann U. A single application of MK801 causes symptoms of acute psychosis, deficits in spatial memory, and impairment of synaptic plasticity in rats. Hippocampus. 2008;18:125-134.
7. Pinault D. N-methyl d-aspartate receptor antagonists ketamine and MK-801 induce wake-related aberrant gamma oscillations in the rat neocortex. Biol Psychiatry. 2008;63:730-735.
8. Kirino E. Correlation between P300 and EEG rhythm in schizophrenia. Clin EEG Neurosci. 2004;35:137-146. (Pubitemid 38828892)
9. Kajimura N, Kato M, Okuma T, Sekimoto M, Watanabe T, Takahashi K. A quantitative sleep-EEG study on the effects of benzodiazepine and zopiclone in schizophrenic patients. Schizophr Res. 1995;15:303-312.
10. Paxinos G, Watson C. The rat brain in stereotaxic coordinates, 6th ed. San Diego: Academic Press; 2007.
11. Takeda Y, Ishida T, Tsutsui R, Toide K, Tanimoto-Mori S, Watanabe S, et al. Studies on somnolence in the daytime caused by drugs used for neuropathic pain. J Pharmacol Sci. 2008; 107:246-250. (Pubitemid 352030310)
12. Tokunaga S, Tsutsui R, Obara Y, Ishida T, Kamei C. Effects of histamine H(1)-antagonists on sleep-awake state in rats placed on a grid suspended over water or on sawdust. Biol Pharm Bull. 2009;32:51-54.
13. Hirase M, Ishida T, Kamei C. Rebound insomnia induced by abrupt withdrawal of hypnotics in sleep-disturbed rats. Eur J Pharmacol. 2008;597:46-50.
14. Ishida T, Kamei C. Characteristic effects of anti-dementia drugs on rat sleep patterns. J Pharmacol Sci. 2009;109:449-455.
15. Hanania T, Negri CA, Dunwiddie TV, Zahniser NR. N-methyl- D-aspartate receptor responses are differentially modulated by noncompetitive receptor antagonists and ethanol in inbred long-sleep and short-sleep mice: behavior and electrophysiology. Alchol Clin Exp Res. 2000;24:1750-1758. (Pubitemid 32001844)
16. Hanania T, Zahniser NR. Locomotor activity induced by noncompetitive NMDA receptor antagonists versus dopamine transporter inhibitors: opposite strain differences in inbred long-sleep and short-sleep mice. Alcohol Clin Exp Res. 2002;26: 431-440. (Pubitemid 34408707)
17. Monti JM, Monti D. The involvement of dopamine in the modulation of sleep and waking. Sleep Med Rev. 2007;11:113-133. (Pubitemid 46330853)
18. Andersen ML, Antunes IB, Silva A, Alvarenga TA, Baracat EC, Tufik S. Effects of sleep loss on sleep architecture in Wistar rats: gender-specific rebound sleep. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:975-983. (Pubitemid 351609232)
19. Machado RB, Hipólide DC, Benedito-Silva AA, Tufik S. Sleep deprivation induced by the modified multiple platform technique: quantification of sleep loss and recovery. Brain Res. 2004;1004:45-51. (Pubitemid 38368061)
20. Maehara S, Hikichi H, Satow A, Okuda S, Ohta H. Anti-psychotic property of a muscarinic receptor agonist in animal models for schizophrenia. Pharmacol Biochem Behav. 2008;91: 140-149.
21. Duncan GE, Moy SS, Lieberman JA, Koller BH. Typical and atypical antipsychotic drug effects on locomotor hyperactivity and deficits in sensorimotor gating in a genetic model of NMDA receptor hypofunction. Pharmacol Biochem Behav. 2006;85: 481-491.
22. Duncan GE, Moy SS, Lieberman JA, Koller BH. Effects of haloperidol, clozapine on sensorimotor gating in a genetic model of reduced NMDA receptor function. Psychopharmacology (Berl). 2006;184:190-200.
23. Kohnomi S, Suemaru K, Kawasaki H, Araki H. Effect of aripiprazole on 5-HT2 receptor-mediated wet-dog shake responses and disruption of prepulse inhibition in rats. J Pharmacol Sci. 2008;106:645-650. (Pubitemid 351556244)
24. Ongini E, Bonizzoni E, Ferri N, Milani S, Trampus M. Differential effects of dopamine D-1 and D-2 receptor antagonist antipsychotics on sleep-wake patterns in the rat. J Pharmacol Exp Ther. 1993;266:726-731. (Pubitemid 23318684)
25. Ma J, Ye N, Cohen BM. Expression of noradrenergic alpha1, serotoninergic 5HT2a and dopaminergic D2 receptors on neurons activated by typical and atypical antipsychotic drugs. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30:647-657.
26. Mathe JM, Nomikos GG, Hildebrand BE, Hertel P, Svensson TH. Prazosin inhibits MK-801-induced hyperlocomotion and dopamine release in the nucleus accumbens. Eur J Pharmacol. 1996;309:1-11. (Pubitemid 26253010)
27. Sharpley AL, Vassallo CM, Cowen PJ. Olanzapine increases slow-wave sleep: evidence for blockade of central 5-HT(2C) receptors in vivo. Biol Psychiatry. 2000;47:468-470.
28. Lindberg N, Virkkunen M, Tani P, Appelberg B, Virkkala J, Rimon R, et al. Effect of a single-dose of olanzapine on sleep in healthy females and males. Int Clin Psychopharmacol. 2002; 17:177-184. (Pubitemid 34686788)
29. Uchida S, Kato Y, Hirano K, Kagawa Y, Yamada S. Brain neurotransmitter receptor-binding characteristics in rats after oral administration of haloperidol, risperidon and olanzapine. Life Sci. 2007;80:1635-1640. (Pubitemid 46412363)
30. Richelson E, Souder T. Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. Life Sci. 2000;68:29-39.
31. Tokunaga S, Takeda Y, Shinomiya K, Hirase M, Kamei C. Effects of some H1-antagonists on the sleep-wake cycle in sleep-disturbed rats. J Pharmacol Sci. 2007;103:201-206. (Pubitemid 46294652)
32. Bastin CH, LeBlanc M, Carrier J, Morin CM. Sleep EEG power spectra, insomnia, and chronic use of benzodiazepines. Sleep. 2003;26:313-317. (Pubitemid 39610679)
33. Van Lier H, Drinkenburg WH, van Eeten YJ, Coenen AM. Effects of diazepam and zolpidem on EEG beta frequencies are behavior-specific in rats. Neuropharmacology. 2004;47:163-174. (Pubitemid 38824640)
34. Kantor S, Jakus R, Bodizs R, Halasz P, Bagdy G. Acute and long-term effects of the 5-HT2 receptor antagonist ritanserin on EEG power spectra, motor activity, and sleep: changes at the light-dark phase shift. Brain Res. 2002;943:105-111. (Pubitemid 34671178)
35. Sharpley AL, Elliott JM, Attenburrow MJ, Cowen PJ. Slow wave sleep in humans: role of 5-HT2A and 5-HT2C receptors. Neuropharmacology. 1994;33:467-471.